Cargando…
Whether adjuvant radiotherapy is desired for postmastectomy patients with T1–T2 tumors and 1–3 positive axillary lymph nodes who received modern systemic therapy?
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797942/ https://www.ncbi.nlm.nih.gov/pubmed/35117076 http://dx.doi.org/10.21037/tcr.2018.11.18 |
_version_ | 1784641675092557824 |
---|---|
author | Lai, Shih-Fan Huang, Chiun-Sheng Kuo, Sung-Hsin |
author_facet | Lai, Shih-Fan Huang, Chiun-Sheng Kuo, Sung-Hsin |
author_sort | Lai, Shih-Fan |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8797942 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-87979422022-02-02 Whether adjuvant radiotherapy is desired for postmastectomy patients with T1–T2 tumors and 1–3 positive axillary lymph nodes who received modern systemic therapy? Lai, Shih-Fan Huang, Chiun-Sheng Kuo, Sung-Hsin Transl Cancer Res Editorial AME Publishing Company 2019-03 /pmc/articles/PMC8797942/ /pubmed/35117076 http://dx.doi.org/10.21037/tcr.2018.11.18 Text en 2019 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/. |
spellingShingle | Editorial Lai, Shih-Fan Huang, Chiun-Sheng Kuo, Sung-Hsin Whether adjuvant radiotherapy is desired for postmastectomy patients with T1–T2 tumors and 1–3 positive axillary lymph nodes who received modern systemic therapy? |
title | Whether adjuvant radiotherapy is desired for postmastectomy patients with T1–T2 tumors and 1–3 positive axillary lymph nodes who received modern systemic therapy? |
title_full | Whether adjuvant radiotherapy is desired for postmastectomy patients with T1–T2 tumors and 1–3 positive axillary lymph nodes who received modern systemic therapy? |
title_fullStr | Whether adjuvant radiotherapy is desired for postmastectomy patients with T1–T2 tumors and 1–3 positive axillary lymph nodes who received modern systemic therapy? |
title_full_unstemmed | Whether adjuvant radiotherapy is desired for postmastectomy patients with T1–T2 tumors and 1–3 positive axillary lymph nodes who received modern systemic therapy? |
title_short | Whether adjuvant radiotherapy is desired for postmastectomy patients with T1–T2 tumors and 1–3 positive axillary lymph nodes who received modern systemic therapy? |
title_sort | whether adjuvant radiotherapy is desired for postmastectomy patients with t1–t2 tumors and 1–3 positive axillary lymph nodes who received modern systemic therapy? |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797942/ https://www.ncbi.nlm.nih.gov/pubmed/35117076 http://dx.doi.org/10.21037/tcr.2018.11.18 |
work_keys_str_mv | AT laishihfan whetheradjuvantradiotherapyisdesiredforpostmastectomypatientswitht1t2tumorsand13positiveaxillarylymphnodeswhoreceivedmodernsystemictherapy AT huangchiunsheng whetheradjuvantradiotherapyisdesiredforpostmastectomypatientswitht1t2tumorsand13positiveaxillarylymphnodeswhoreceivedmodernsystemictherapy AT kuosunghsin whetheradjuvantradiotherapyisdesiredforpostmastectomypatientswitht1t2tumorsand13positiveaxillarylymphnodeswhoreceivedmodernsystemictherapy |